Gensulin®/ SciLin™

1. Product Overview

Gensulin®/SciLin™ is a recombinant human insulin developed and distributed by SciGen, part of its endocrine healthcare product portfolio. This product is manufactured to European pharmaceutical standards to ensure quality, safety, and efficacy. The insulin is almost identical to natural human insulin, reducing the risk of allergies or immune reactions, while effectively controlling blood sugar. The product targets emerging markets to improve access to quality insulin for patients.

2. Dosage Forms and Characteristics

• SciLin R (Regular human insulin): Fast-acting insulin, injectable solution, typically used before meals to control post-meal blood sugar spikes.

• SciLin N (Isophane/NPH human insulin): Intermediate/slow-acting insulin, injectable suspension, helps maintain stable blood sugar between meals or overnight.

• SciLin M30 (30/70): A mixture of 30% fast-acting insulin and 70% intermediate-acting insulin, providing continuous blood sugar control, suitable for both mealtime and basal needs, ideal for patients requiring a balance between rapid and long-lasting effects.

3. Indications and Uses

• Treatment for patients with type 1 diabetes, who are insulin-dependent.

• Treatment for patients with type 2 diabetes when oral medications are insufficient to control blood sugar or in special situations such as surgery, infection, or high stress.

• Blood sugar control to reduce the risk of long-term complications of diabetes such as nerve damage, cardiovascular issues, kidney problems, and vascular damage.

4. Advantages and Highlights

• European quality product, ensuring stability and safety.

• Available in multiple flexible dosage forms (R, N, M30), suitable for individual treatment needs.

• Wide accessibility for emerging markets, with reasonable costs while maintaining high quality.

5. Limitations, Warnings, and Usage Notes

• Must adhere to the correct indications, dosage, and injection method as directed by a doctor or pharmacist.

• May cause hypoglycemia if overdosed, or hyperglycemia if underdosed.

• May cause injection site reactions such as allergies or lipodystrophy.

• For pregnant women, the elderly, patients with liver/kidney failure, close monitoring and adherence to doctor's instructions are required.

6. Summary of Usage Value

Gensulin®/SciLin™ is a high-quality human insulin solution, meeting diverse blood sugar control needs for diabetic patients, combining clinical efficacy, safety, stability, and global market accessibility. The product aligns with SciGen's mission to improve access to quality healthcare products for patients worldwide.